Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026)
Contineum Therapeutics (CTNM) recorded quarterly Other Non Operating Income of -$57000.0 in Q1 2026, down 11.76% quarter-over-quarter from -$51000.0 in Q4 2025, and up 56.15% on a YoY basis from -$36502.5 in Q1 2025.
Contineum Therapeutics (CTNM) Other Non Operating Income (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$57000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 56.15% year-over-year to -$57000.0; the TTM figure through Mar 2026 stood at -$92000.0 (up 68.06% YoY), while the FY2025 annual figure was -$165000.0, down 1.23% from the prior year.
- Other Non Operating Income was -$57000.0 for Q1 2026 at Contineum Therapeutics, down from -$51000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $257000.0 in Q4 2023 to a low of -$167000.0 in Q2 2025.
- Historically, Other Non Operating Income has averaged -$19923.1 across 4 years, with a median of -$47000.0 in 2024.
- Biggest YoY gain for Other Non Operating Income was 638.24% in 2025; the steepest drop was 2066.67% in 2025.
- A 4-year view of Other Non Operating Income shows it stood at $257000.0 in 2023, then plunged by 118.29% to -$47000.0 in 2024, then dropped by 8.51% to -$51000.0 in 2025, then declined by 11.76% to -$57000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$57000.0 (Q1 2026), -$51000.0 (Q4 2025), and $183000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Contineum Therapeutics | 423.05 Mn | 423.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -57,000.00 |
| Dec 31, 2025 | -51,000.00 |
| Sep 30, 2025 | 183,000.00 |
| Jun 30, 2025 | -167,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | -47,000.00 |
| Sep 30, 2024 | -34,000.00 |
| Jun 30, 2024 | -77,000.00 |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 257,000.00 |
| Sep 30, 2023 | -36,000.00 |
| Jun 30, 2023 | -76,000.00 |
| Mar 31, 2023 | -18,000.00 |